FOLD - Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2021 Results - Earnings Call Transcript

Amicus Therapeutics, Inc. (FOLD) Q4 2021 Earnings Conference Call February 24, 2022 8:30 AM ET Company Participants Andrew Faughnan – Executive Director-Investor Relations John Crowley – Chairman and Chief Executive Officer Bradley Campbell – President and Chief Operating Officer Daphne Quimi – Chief Financial Officer Jeff Castelli – Chief Development Officer Conference Call Participants Ritu Baral – Cowen Anupam Rama – JPMorgan Joseph Schwartz – SVB Leerink Dae Gon Ha – Stifel Tazeen Ahmad – Bank of America Kristen Kluska – Cantor Fitzgerald Yun Zhong – BTIG Gil Blum – Needham & Company Robert Finke – Guggenheim Zhi Shu – Berenberg Presentation Operator Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics’ Full Year 2021 Financial Results Conference Call and Webcast. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Executive

For further details see:

Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2021 Results - Earnings Call Transcript